Publications

Zieliński M, Lenartowicz-Gasik A, Misiarz A, Rzadkiewicz J, Kocik J. Cellular response of MCF-7 and MCF-12A cell line to conventional versus ultra-high dose rate radiotherapy: analysis of proteins involved in the protection of cells against oxidative stress and the regulation of reactive oxygen species (ROS). Current Topics in Peptide and Protein Research 2024; accepted.

Zieliński M, Lenartowicz-Gasik A, Misiarz A, Rzadkiewicz J, Kocik J. Comparison of conventional versus ultra-high dose rate radiotherapy in MCF-7 and MCF-12A human breast cells: analysis of DNA damage response proteins. Current Topics in Peptide and Protein Research 2024; accepted.

Janowska J, Gargas J, Zajdel K, Wieteska M, Lipinski K, Ziemka-Nalecz M, Frontczak-Baniewicz M, Sypecka J. Oligodendrocyte progenitor cells’ fate after neonatal asphyxia – puzzling implications for the development of hypoxic-ischemic encephalopathy. Brain Pathology 2024; e13255. DOI: doi.org/10.1111/bpa.13255.

Wrzosek B, Zajdel K, Jeleń P, Bukowska J. Mellitic acid-supported synthesis of anisotropic nanoparticles used as SERS substrate. ACS Omega 2024; 9:34905–34917. DOI: 10.1021/acsomega.4c04592.

Krzyczmonik A, Keller T, Kerminen E, Solin O, Kirjavainen AK. Simple method for the production of [11C]phosgene. Nuclear Medicine and Biology 2022; 108-109:S72-S73. DOI: 10.1016/S0969-8051(22)00177-9.

Kalinowska M, Gryko K, Gołębiewska E, Świderski G, Lewandowska H, Pruszyński M, Zawadzka M, Kozłowski M, Sienkiewicz-Gromiuk J, Lewandowski W. Fe(III) and Cu(II) Complexes of Chlorogenic Acid: Spectroscopic, Thermal, Anti-/Pro-Oxidant, and Cytotoxic Studies. Materials 2022; 15:6832. DOI: 10.3390/ma15196832.

Radchenko V, Morgenstern A, Jalilian AR, Ramogida CF, Cutler C, Duchemin C, Hoehr C, Haddad F, Bruchertseifer F, Gausemel H, Yang H, Osso JA, Washiyama K, Czerwinski K, Leufgen K, Pruszyński M, Valzdorf O, Causey P, Schaffer P, Perron R, Maxim S, Wilbur DS, Stora T, Li Y. Production and supply of α-particle-emitting radionuclides for Targeted α-Therapy. Journal of Nuclear Medicine 2021; 62(11):1495–1503. DOI: 10.2967/jnumed.120.261016.

Kalinowska M, Lewandowska H, Pruszyński M, Świderski G, Gołębiewska E, Gryko K, Braun J, Borkowska M, Konieczna M, Lewandowski W. Co(II) complex of quercetin–spectral, anti‐/pro‐oxidant and cytotoxic activity in HaCaT cell lines. Applied Sciences 2021; 11(19):9244. DOI: 10.3390/app11199244.

Kalinowska M, Gołębiewska E, Mazur L, Lewandowska H, Pruszyński M, Świderski G, Wyrwas M, Pawluczuk N, Lewandowski W. Crystal structure, spectroscopic characterization, antioxidant and cytotoxic activity of new Mg(II) and Mn(II)/Na(I) complexes of isoferulic acid. Materials 2021; 14(12):3236. DOI: 10.3390/ma14123236.



This project has received funding from the European Union Horizon 2020 research and innovation
programme under grant agreement No 857470 and from European Regional Development Fund
via Foundation for Polish Science International Research Agenda PLUS programme grant
No MAB PLUS/2018/8.
Poland
The project is co-financed from the state budget within the framework of the undertaking of the Minister of Science and Higher Education "Support for the activities of Centers of Excellence established under Horizon 2020".

Grant: 5 143 237,70 EUR
Total value: 29 971 365,00 EUR
Date of signing the funding agreement: December 2023

The purpose of the undertaking is to support entities of the higher education and science system that have received funding from the European Union budget in the competition H2020-WIDESPREAD-2018-2020/WIDESPREAD-01-2018-2019: Teaming Phase 2. in the preparation, implementation and updating of activities, maintenance of material resources necessary for carrying out activities, acquisition and modernization of scientific and research apparatus, maintenance and development of personnel potential necessary for the implementation of activities, and dissemination of the results of scientific activities.